Home  >  Products  >  F7 (coagulation factor VII (serum prothrombin conversion accelerator)) Blocking Peptide (the middle region of F7)(100ug)
F7 (coagulation factor VII (serum prothrombin conversion accelerator)) Blocking Peptide (the middle region of F7)(100ug)

F7 (coagulation factor VII (serum prothrombin conversion accelerator)) Blocking Peptide (the middle region of F7)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-F7 Antibody (ARP60039_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP60039
Size: 100ug
Weight: 28kDa
Gene: 2155
Format: Lyophilized powder
Target: This gene encodes coagulation factor VII which is a vitamin K-dependent factor essential for hemostasis. This factor circulates in the blood in a zymogen form, and is converted to an active form by either factor IXa, factor Xa, factor XIIa, or thrombin by minor proteolysis. Upon activation of the factor VII, a heavy chain containing a catalytic domain and a light chain containing 2 EGF-like domains are generated, and two chains are held together by a disulfide bond. In the presence of factor III and calcium ions, the activated factor then further activates the coagulation cascade by converting factor IX to factor IXa and/or factor X to factor Xa. Alternative splicing of this gene results in 2 transcripts. Defects in this gene can cause coagulopathy.
See Full Product Listings >